Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy

Seizure

Volumn 20, Issue 1, 2011, Pages 72-79

  Dedeurwaerdere, S ^a,b   Van Raay, L ^a   Morris, M J ^c   Reed, R C ^d,f   Hogan, R E ^e   O'Brien, T J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d HUSSON UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Abbott R and D ^*  (United States)

Author keywords

Absence epilepsy; GAERS; Kainic acid; Slow release formulation; Status epilepticus; Temporal lobe epilepsy

Indexed keywords

KAINIC ACID; SODIUM CHLORIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE CONTROL; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG PENETRATION; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; EPILEPSY; EPILEPSY, ABSENCE; FEMALE; INFUSION PUMPS; MALE; RATS; RATS, MUTANT STRAINS; VALPROIC ACID;

EID: 78650801288     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2010.10.011     Document Type: Article

References (46)

1. E. Perucca Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience CNS Drugs 16 2002 695 714
2. A.G. Marson, A.M. Al-Kharusi, M. Alwaidh, R. Appleton, G.A. Baker, and D.W. Chadwick The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1016 1026 (Pubitemid 46436125)
3. M. Giroud, and R. Dumas Treatment of status epilepticus by sodium valproate Neurophysiol Clin 18 1988 21 32
4. R. Davis, D.H. Peters, and D. McTavish Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy Drugs 47 1994 332 372
5. C.L. Bowden, and V. Singh Valproate in bipolar disorder: 2000 onwards Acta Psychiatr Scand Suppl 2005 13 20
6. K. Kultima, A.M. Nystrom, B. Scholz, A.L. Gustafson, L. Dencker, and M. Stigson Valproic acid teratogenicity: a toxicogenomics approach Environ Health Perspect 112 2004 1225 1235
7. F.J. Vajda, T.J. O'Brien, A. Hitchcock, J. Graham, M. Cook, and C. Lander Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy J Clin Neurosci 11 2004 854 858
8. M.P. Grillo, G. Chiellini, M. Tonelli, and L.Z. Benet Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats Drug Metab Dispos 29 2001 1210 1215
9. M.G. Neuman, N.H. Shear, P.M. Jacobson-Brown, G.G. Katz, H.K. Neilson, and I.M. Malkiewicz CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity Clin Biochem 34 2001 211 218
10. K.W. Sommerville, S. Dutta, V. Biton, Y. Zhang, J.C. Cloyd, and B. Uthman Bioavailability of a divalproex extended-release formulation versus the conventional divalproex formulation in adult patients receiving enzyme-inducing antiepileptic drugs Clin Drug Invest 23 2003 661 670
11. J.M. Pellock, M.C. Smith, J.C. Cloyd, B. Uthman, and B.J. Wilder Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy Epilepsy Behav 5 2004 301 307
12. M.C. Smith, F. Centorrino, J.A. Welge, and M.A. Collins Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials Epilepsy Behav 5 2004 746 751
13. J.L. Herranz, R. Arteaga, J. Adin, and J.A. Armijo Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics Eur J Clin Pharmacol 62 2006 805 815
14. H. Nau Teratogenic valproic acid concentrations: infusion by implanted minipumps vs. conventional injection regimen in the mouse Toxicol Appl Pharmacol 80 1985 243 250
15. H. Van Duijn, J.W.A. Meijer, J.P. Segers, C. Gardner-Thorpe, D. Janz, and H. Meinardi To what extent is drug entry into brain dependent on the way of administration. Some dipropylacetic acid experiments on cats Antiepileptic drug monitoring 1977 Pitman Medical Publishing Co. Kent
16. U. Altrup, G. Gerlach, H. Reith, M.N. Said, and E.J. Speckmann Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia). I. Antiepileptic actions Epilepsia 33 1992 743 752
17. A. Lucke, A. Lehmenkuhler, U. Altrup, C. Nicholson, H. Reith, and C. Schmitz-Moormann Diffusion analysis of valproate and trans-2-en-valproate in agar and in cerebral cortex of the rat Brain Res 631 1993 187 190
18. W. Loscher, and D. Honack Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous ("controlled release") administration in a model of generalized seizures in rats Epilepsia 36 1995 929 937
19. M. Thibault, W.T. Blume, J.M. Saint-Hilaire, R. Zakhari, and K.W. Sommerville Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures Epilepsy Res 50 2002 243 249
20. C. Marescaux, M. Vergnes, and A. Depaulis Genetic absence epilepsy in rats from Strasbourg - a review J Neural Transm Suppl 35 1992 37 69
21. J.P. Leite, and E.A. Cavalheiro Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats Epilepsy Res 20 1995 93 104
22. J. Nissinen, and A. Pitkanen Effect of antiepileptic drugs on spontaneous seizures in epileptic rats Epilepsy Res 73 2007 181 191
23. E.A. van Vliet, P.M. Edelbroek, and J.A. Gorter Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats Epilepsia 2009
24. K. Morimoto, M. Fahnestock, and R.J. Racine Kindling and status epilepticus models of epilepsy: rewiring the brain Prog Neurobiol 73 2004 1 60
25. E. Perucca, L. Gram, G. Avanzini, and O. Dulac Antiepileptic drugs as a cause of worsening seizures Epilepsia 39 1998 5 17
26. J.L. Hellier, P.R. Patrylo, P.S. Buckmaster, and F.E. Dudek Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy Epilepsy Res 31 1998 73 84
27. K.L. Powell, C. Ng, T.J. O'Brien, S.H. Xu, D.A. Williams, and S.J. Foote Decreases in HCN mRNA expression in the hippocampus after kindling and status epilepticus in adult rats Epilepsia 49 2008 1686 1695
28. L. van Raay, M.J. Morris, R.C. Reed, T.J. O'Brien, and S. Dedeurwaerdere A novel system allowing long-term simultaneous video-electroencephalography recording, drug infusion and blood sampling in rats J Neurosci Meth 179 2009 184 190
29. G. Micheletti, M. Vergnes, C. Marescaux, J. Reis, A. Depaulis, and L. Rumbach Antiepileptic drug evaluation in a new animal model: spontaneous petit mal epilepsy in the rat Arzneimittelforschung 35 1985 483 485
30. A. Molino, and D.C. McIntyre Another inexpensive headplug for the electrical recording and or stimulation of rats Physiol Behav 9 1972 273 275
31. T.L. Arens, and G.M. Pollack Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding Biopharm Drug Dispos 22 2001 243 249
32. R.J. Racine Modification of seizure activity by electrical stimulation. II. Motor seizure Electroencephalogr Clin Neurophysiol 32 1972 281 294
33. H. Nau, and W. Loscher Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse J Pharmacol Exp Ther 220 1982 654 659 (Pubitemid 12152184)
34. W. Loscher, J.E. Fisher, H. Nau, and D. Honack Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment J Pharmacol Exp Ther 250 1989 1067 1078
35. J.F. Rothrock, and J.E. Mendizabal An analysis of the "carry-over effect" following successful short-term treatment of transformed migraine with divalproex sodium Headache 40 2000 17 19
36. W. Loscher, and H. Nau Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment J Pharmacol Exp Ther 226 1983 845 854
37. J. Brill, M. Lee, S. Zhao, R.D. Fernald, and J.R. Huguenard Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami J Neurosci 26 2006 6813 6822
38. W. Loscher Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action Prog Neurobiol 58 1999 31 59
39. F. Noe, A.H. Pool, J. Nissinen, M. Gobbi, R. Bland, and M. Rizzi Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy Brain 131 2008 1506 1515
40. M.J. Morris, E. Gannan, L.M. Stroud, A.G. Beck-Sickinger, and T.J. O'Brien Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors Eur J Neurosci 25 2007 1136 1143
41. L.M. Stroud, T.J. O'Brien, B. Jupp, C. Wallengren, and M.J. Morris Neuropeptide Y suppresses absence seizures in a genetic rat model Brain Res 1033 2005 151 156
42. N. Detich, V. Bovenzi, and M. Szyf Valproate induces replication- independent active DNA demethylation J Biol Chem 278 2003 27586 27592
43. S. Milutinovic, A.C. D'Alessio, N. Detich, and M. Szyf Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes Carcinogenesis 28 2007 560 571
44. P.M. Jeavons, and J.E. Clark Sodium valproate in treatment of epilepsy Brit Med J 2 1974 584 586
45. P. Genton Progress in pharmaceutical development presentation with improved pharmacokinetics: a new formulation for valproate Acta Neurol Scand Suppl 182 2005 26 32
46. R.C. Reed, S. Dutta, and W. Liu Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapy Epilepsy Res 87 2009 260 267